BerGenBio ASA - Ex. reverse share split and change of ISIN today
Issuer name: BerGenBio ASAEx. date: 30 May 2024Type of corporate action: Reverse share splitReverse split ratio: One hundred (100) old shares give one (1) new share. New par value per share: NOK 10 New ISIN: NO 001 3251173 New number of shares outstanding: 39,087,116 For further information, please contact: Martin Olin, CEO, BerGenBio ASAir@bergenbio.com Rune Skeie, CFO, BerGenBio ASArune.skeie@bergenbio.com About BerGenBio ASA BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential